These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 2616207

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [The hypolipidemic activity of natural substances].
    Okunevich IV, Kliueva NN, Solov'eva MA, Triufanov VF, Ryzhenkov VE.
    Eksp Klin Farmakol; 1992; 55(5):44-7. PubMed ID: 1305452
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of L-DOPA on the development of experimental hyperlipidemia and atherosclerosis].
    Mosina IV, Ryzhenkov VE.
    Biull Eksp Biol Med; 1981 Mar; 91(3):270-1. PubMed ID: 7248493
    [No Abstract] [Full Text] [Related]

  • 11. [The effect of ximedon on cholesterol metabolism and experimental atherosclerosis in rabbits].
    Dautova GS, Kosykh VA, Repin VS, Kamburg RA, Ibragimov OB, Popova LG, Valeeva IKh.
    Eksp Klin Farmakol; 1995 Mar; 58(1):25-9. PubMed ID: 7787689
    [Abstract] [Full Text] [Related]

  • 12. Hypolipemic and potential antiatherosclerotic properties of diprophyllinyl-4-benzyloxybenzoate.
    Wójcicki J, Samochowiec L, Dadej R, Jaworska M, Gawrońska-Szklarz B, Kownacka A, Ryshenkov V, Chistyakova A, Acsenova N.
    Pol J Pharmacol Pharm; 1987 Mar; 39(4):343-51. PubMed ID: 3449807
    [Abstract] [Full Text] [Related]

  • 13. [The angioprotector and hypolipemic activity of leukomizin in experimental atherosclerosis].
    Kirmukov AG, Aĭzikov MI, Rasulova SA, Sidiakin GP, Sham'ianov ID, Malikov VM.
    Farmakol Toksikol; 1991 Mar; 54(3):35-7. PubMed ID: 1915817
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [An enterosorbent with trimethylaminoethanol chloride. 2. Hypolipidemic action and effect on cholesterol absorption in the intestine (experimental data)].
    Ryshenkov VE, Samoĭlova NA, Chistiakova AM, Frolova IuV, Lapuk IaI, Iamskov IA.
    Vopr Med Khim; 1995 Mar; 41(1):34-5. PubMed ID: 7771088
    [Abstract] [Full Text] [Related]

  • 17. [Anti-atherosclerotic action of mildronate in experiment].
    Okunevich IV, Ryzhenkov VE.
    Patol Fiziol Eksp Ter; 2002 Mar; (2):24-7. PubMed ID: 12152427
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and hypolipidemic activities of novel 2-[4-[diethoxyphosphoryl)methyl]phenyl]quinazolines and 4(3H)-quinazolinones.
    Kurogi Y, Inoue Y, Tsutsumi K, Nakamura S, Nagao K, Yoshitsugu H, Tsuda Y.
    J Med Chem; 1996 Mar 29; 39(7):1433-7. PubMed ID: 8691473
    [Abstract] [Full Text] [Related]

  • 19. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
    Nachtigal P, Pospisilova N, Jamborova G, Pospechova K, Solichova D, Andrys C, Zdansky P, Micuda S, Semecky V.
    Life Sci; 2008 Mar 26; 82(13-14):708-17. PubMed ID: 18289605
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.